You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

December 14, 2012

Managing Intellectual Property for Entrepreneurs

Bangkok Post, Corporate Counsellor Column

On September 10, 2009, the Thai government established the National Creative Economy Policy Committee to set guidelines and translate policy into action by various government agencies. This led to the Creative Thailand program, which was intended to encourage the growth and competitiveness of businesses through creativity and research and development. Intellectual property rights (IPRs) play a crucial role in moving this policy forward.

Although the government has attempted to promote IPRs to the public through several channels, including publications and conferences, many business owners—especially entrepreneurs and new ventures—fail to understand the key link between IPRs and the success of their enterprise. If you are an entrepreneur or new venture, this article will provide you with guidelines for effectively managing your IPRs.

Guidance for IPR Users

Some companies develop their own IPRs, while others are simply IPR users. The latter model does not rely on creating IPRs; instead, the company may seek permission from the rights holder to use the rights. For businesses such as distributors and franchisees that rely on this model, there are two important keys to be considered:

• Conduct an IP survey: Entrepreneurs and new ventures should supplement their standard market surveys by conducting an IP survey in order to understand what IPRs already exist in the market and how to avoid infringing them.

For example, if you are going to use a new brand with your products, you should conduct a trademark search at the Department of Intellectual Property (DIP) to determine whether anyone has already registered the same or a similar mark in Thailand. When introducing a new technology, a patent search will show whether your new product—or the technology involved in producing it—is already protected as a patent in Thailand. For complex technologies, a more thorough “Freedom-to-Operate” report from an IP lawyer may be required to make sure your product does not infringe an existing patent registration.

• Register your licensing agreement: If your business operates by using IPRs owned by others, you need to register your trademark licensing agreement or patent licensing agreement with the DIP. If you fail to do so, the agreement will be void and non-enforceable between the affected parties.

In a franchise agreement that includes a clause for the franchisor to grant trademark or patent rights to the franchisee, the franchise agreement should similarly be registered as a licensing agreement.

By registering the licensing agreement, you will protect your company when you use or sell products bearing the registered IPR, and the licensee or franchisee can fully exercise the rights under the law.

Additional Steps for IPR Owners

Companies that move beyond merely using IPRs and begin to innovate will likely hold a wide range of IPRs—not only trademarks, copyrights, patents, and trade secrets, but also domain names, websites, know-how, and more. These IPRs are important company assets and must be managed effectively so they can contribute to revenue growth and profitability. Companies that are creating their own IPRs should be sure to take the following four steps:

1. Take an initial inventory: Knowing what IP you have, what your IPRs are worth, how your IPRs are protected, and how they should be protected will help you get the maximum value from your creation and development. This can be difficult for a new venture, which may not know much about IP law and the scope of IPR protection. At this first stage, you may need to consult with your company’s legal adviser. Then you can evaluate the IPRs within the company’s broader portfolio of assets and implement the proper measures to manage them.

2. Ensure compliance: By obtaining full protection of your IPRs under the law, you can ensure compliance while also contributing to your company’s bottom line. For example, if you create a new trademark or brand, you should register the trademark or brand with the DIP. If you come up with a unique idea or invention, obtaining patent protection will give you the exclusive right over the invention and prevent unauthorized use by your competitors. Your company may consider recording copyrighted works with the DIP to prove the company’s IPRs more easily in the future.

Without the proper protection, some IP may be walking right out the company’s door through employees, former employees, or visitors who are using e-mail, data storage devices, the telephone, or just taking things home. Today’s employees may be tomorrow’s competitors.

3. Create an IP portfolio: After initially managing your IPRs, collecting and keeping evidence to prove that your company is the true owner of these IPRs is necessary so that you will be prepared in the event of any infringement or opposition in the future. Trademark owners should collect documents demonstrating the use of the trademark in Thailand, such as advertisements, invoices showing sales figures of the mark, etc., to prove the well-known status of the mark in Thailand. It is also crucial to manage the deadline or expiration date for each of your IPR registrations to ensure timely payment of annuity fees or renewal fees.

4. Enforce and exploit rights: Monitoring and enforcing your IPRs is also essential, as the more popular your products become, the higher the chance your IPRs will be infringed. If you learn that a competitor has infringed your IPRs, you should enforce your rights through the relevant government authorities such as through raids against infringers or administrative methods, such as sending a cease-and-desist letter or mediation through the DIP.

By taking the simple steps outlined above, you can ensure your IPRs are well protected, which in turn will set a strong foundation for future innovation, faster growth, and improved profitability.

RELATED INSIGHTS​ 

July 30, 2025
Artificial intelligence (AI) model training and data scraping are essential processes in the development of modern AI systems. AI model training involves using large datasets to teach machine learning algorithms to recognize patterns, make predictions, or generate new content. Data scraping refers to the automated extraction of information from websites or digital sources, often to assemble the vast datasets required for effective AI training. As these practices become more widespread, questions about the legality of using third-party content—especially copyrighted works—have become increasingly important. In Thailand, the legal landscape for AI developers is shaped primarily by the Copyright Act, which presents unique challenges due to the absence of a fair-use exception. This article examines the copyright-related risks and legal uncertainties facing AI developers under Thailand’s current copyright law and practices, offering strategic guidance for navigating this complex environment. Copyright Risks in AI Scraping and Training Thailand’s Copyright Act does not provide a broad fair use or fair dealing exception, unlike some other jurisdictions, such as the United States. This absence has significant consequences for AI developers: No general defense for AI training: Any use of copyrighted material for AI model training is presumed to be infringing unless a specific, narrow statutory exception applies or explicit permission is obtained from the rights holder. There is no general legal basis for using copyrighted works in AI training without authorization. Increased rights clearance burden: Developers must identify and secure licenses for every copyrighted work included in their training datasets. Given the scale and diversity of data required for effective AI models, this process can be both impractical and costly. Legal ambiguity and litigation risk: The lack of clear statutory guidance or case law leaves developers in a legal gray area. There is no established precedent clarifying whether certain uses of copyrighted material for
July 25, 2025
Over the first half of 2025, the government of Vietnam has implemented a comprehensive suite of legislative reforms that significantly impact the country’s intellectual property (IP) framework. These amendments, most of which took effect on 1 July 2025, span the criminal, civil, administrative, and judicial sectors, and are part of a broader initiative to modernize Vietnam’s legal infrastructure, strengthen enforcement mechanisms, and harmonize domestic regulations with international standards. A summary of the key legislative changes and their potential implications for IP protection and enforcement across Vietnam is provided below. Criminal Code: Stricter penalties Under the 2025 amendments to Vietnam’s Criminal Code, penalties for offenses involving the manufacturing and trading of counterfeit goods have been significantly escalated. Individuals convicted of such violations now face fines ranging from VND 200 million to VND 2 billion (approximately USD 7,700 to USD 77,000; up from VND 100 million to VND 1 billion). For corporate entities, the penalties are even more severe, with fines ranging from VND 2 billion to VND 40 billion (roughly USD 77,000 to USD 1.54 million; up from VND 1 billion to VND 20 billion). These heightened penalties reflect the government’s intensified efforts to deter counterfeit-related crimes and protect consumer rights. Law on Handling Administrative Violations: Extended statute of limitations and application of electronic procedure The statute of limitations for addressing administrative violations in the IP sector is still two years. However, in cases where such violations are referred by procedural authorities, this period is extended by one year. The time taken by these authorities to process the case is now included within the overall limitation period. In addition, the Law on Handling Administrative Violations facilitates the use of electronic procedures, provided that the necessary infrastructure, technical systems, and information conditions are in place. Specifically, enforcement authorities are now permitted
July 21, 2025
Distinctiveness is a fundamental requirement for a trademark’s registration and protection under Thai law. The Thai courts typically assess distinctiveness based on a mark’s inherent characteristics rather than its use, as proving acquired distinctiveness through use requires substantial evidence, including the duration of use, extent of distribution and promotional efforts. However, the Intellectual Property and International Trade Court (IP & IT Court) has recently ruled that the figurative mark WEPLAY had acquired distinctiveness through use – an uncommon ruling under Thai trademark law. Subsequently, the Court of Appeal for Specialised Cases affirmed the mark’s inherent distinctiveness based on a holistic assessment of its components. This article discusses the criteria for proving both inherent and acquired distinctiveness, offering examples from both courts to provide valuable insights into case preparation and understanding of how the courts assess distinctiveness. Background In 2017 the plaintiff filed a trademark application for the mark depicted below for goods in Class 28, including toy building blocks: The registrar rejected the application on the grounds of non-distinctiveness under Section 7 of the Trademark Act. The plaintiff appealed to the Board of Trademarks, which considered that, when the term ‘weplay’ is used for goods in Class 28, it is descriptive of the nature of the goods applied for as “playthings”. Therefore, ‘weplay’ was deemed nondistinctive under Section 7, Paragraph 2(2) of the Trademark Act. IP & IT Court decision In 2024 the IP & IT Court ruled that the term ‘weplay’ is not a coined or invented word; instead, it is a combination of ‘we’ and ‘play’, conveying the meaning of ‘we play’. When the term is used for goods in Class 28, it describes the nature of the goods as “playthings”. Consequently, the mark was deemed non-distinctive. However, the court considered the evidence presented by the plaintiff,
July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support